Surprising Research Indicates Chemotherapy Restores Inactive Cancer Cells – Causes Metastasis

The homepage features 60 new headlines daily. Check it out for updates.

(Note: We appreciate your support for the businesses presenting sponsored messages below.)

Nicholas Halsher, MPH, Research highlights from Dr. Peter McCullough

Chemotherapy is designed to eliminate cancer, not reactivate it. Yet, recent findings indicate that common drugs like doxorubicin and cisplatin can awaken dormant tumor cells, especially in the lungs, which can lead to lethal recurrences.

These dormant cancer cells, referred to as disseminated tumor cells (DTCs), can remain hidden for years before becoming active again. This research is the first to clearly demonstrate that chemotherapy can trigger this reactivation.

Key findings from the study include:

1. Chemotherapy triggers dormant cancer cells

   • Using specific tracers, researchers found that chemotherapy-treated mice had previously dormant cancer cells enter the cell cycle again.

   • These revived cells led to aggressive lung metastases weeks after chemotherapy, even with the primary tumor removed.

   • This phenomenon was unique to dormant cells; chemotherapy suppressed active tumors while inadvertently activating the dormant ones.

2. A neutrophil extracellular trap triggers this process

   • While chemotherapy targeted cancer cells, it also caused lung fibroblasts to enter a state of biological aging.

   • These senescent cells released proinflammatory signals that activated neutrophils, a type of white blood cell.

   • Neutrophils then created traps composed of DNA and enzymes like MMP9 and neutrophil elastase, altering the lung environment and directly waking the dormant DTCs.

3. SASP proteins fuel the cycle

   • Senescent fibroblasts released a harmful mixture known as the SASP (senescence-associated secretory phenotype).

   • Three crucial factors — Complement C3, Macrophage migration inhibitor (MIF), and CXCL1 – were identified as key players in the trap formation.

   • Mice that lacked C3 exhibited significantly reduced trap activity and fewer instances of metastasis after chemotherapy.

4. Blocking traps and clearing senescent cells stops recurrence

   • Administering DNase I (dismantling the traps) or GSK484 (inhibiting trap formation) completely halted chemotherapy-induced metastasis in mice.

   • The combination of Dasatinib + Quercetin (for aging) helped clear aged fibroblasts, stopping the entire chain reaction — controlling the primary tumor and preventing recurrence.

   • Notably, this combination didn’t hinder the effectiveness of chemotherapy on the primary tumor.

5. This mechanism is seen in humans

   • In patients with breast cancer, lung metastases were denser post-chemotherapy, with significantly increased levels of C3, MIF, and CXCL1.

   • Blood analyses revealed spikes in C3 and MIF after treatment, particularly in patients who later experienced lung recurrences.

   • These markers could serve aspredictive biomarkers for recurrence risk in future assessments.

Halsher’s conclusion:

This study reshapes our understanding of traditional cancer treatments. While chemotherapy may control primary tumors, it can inadvertently encourage future metastasis by reactivating hidden cancer cells through inflammatory responses. Combining chemotherapy with cenolytics or net inhibitors could significantly lower recurrence rates, and initial trials are already underway.

There’s an urgent need to investigate cancer treatments that don’t compromise the entire body or reactivate dormant cells, like: Ivermectin.

A potential breakthrough treatment

Medical institutions should promptly pursue alternatives to chemotherapy, as it’s a profitable avenue for large pharmaceutical companies, which may hinder the exploration of effective, low-cost treatments.

Luckily, healthcare professionals like Dr. Peter McCullough are dedicated to seeking safe, effective, and affordable healthcare solutions. They are currently exploring the potential of Ivermectin in cancer treatment.

Recent studies show early, promising results. According to the McCullough Foundation:

Research titled “”Review of Ivermectin Use in Cancer Patients: Is it time to reuse ivermectin in cancer treatment?” has just been published in the journal Acta Poloniae Pharmaceutica – Drug Research…

This comprehensive review indicates that ivermectin appears safe, backed by a range of anticancer mechanisms observed in preclinical models and anecdotal evidence of cancer improvements, supporting its potential for reuse as a treatment. Large, well-structured clinical trials should begin immediately to fully evaluate its cancer treatment possibilities.

Additionally, Ivermectin in combination with Mebendazole shows even more promise against various cancers.

Mebendazole, an antiparasitic, has been in use for over a century to combat parasites – and according to the CDC, over 60 million Americans carry them in their bodies.

Reliable medications from trusted providers

Healthcare professionals at Wellness Company (including Dr. Peter McCullough and Dr. Kelly’s team) led efforts to provide accurate medical information to the public during Covid. These experts prioritize patient health over profit.

Currently, the wellness company uniquely offers a high-dose shared treatment of ivermectin and mebendazole for a 90-day supply.

Ivermectin – Nobel Prize-winning research supports its effectiveness for treating parasite infections, ensuring well-being for families.

Mebendazole – Trusted by medical professionals, it effectively targets and eradicates intestinal parasites, securing the health of families.

Explore Wellness Company today for Ivermectin + Mebendazole to order a 90-day parasite cleanse. Filling out a quick intake survey after checkout completes your prescription request.

What patients are saying Wellness Company Ivermectin + Mebendazole:

I wholeheartedly appreciate having access to Ivermectin and mebendazole, and I trust that the wellness company produces safe products in our country. It gives me peace of mind knowing that I take what’s accurately labeled. – Jennifer W.

After my daughter was diagnosed with cancer, she started Ivermectin/mebendazole two weeks ago. A recent scan showed her lungs are better than before. Thank you for the hope and healing! – Helen

Order Ivermectin and Mebendazole from Wellness Company today.

This information is for educational purposes only and shouldn’t replace professional medical advice. It’s your responsibility to adhere to all laws and guidelines concerning prescription drugs.